Pioneering Molecular Immune Cell Quantification

Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system 


Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood


21 Sep 2022

Epimune's clinical partners at Stanford University publish new study in the Journal of Allergy and Clinical Immunology.

12 Jul 2022

Epimune wins important regulatory milestones for i.Mune TBNK® [CE]

For a Spanish version of this video please click here!